RU95102717A - Method for treatment of purulent septic complications
- Google Patents
Method for treatment of purulent septic complications
Info
Publication number
RU95102717A
RU95102717ARU95102717/14ARU95102717ARU95102717ARU 95102717 ARU95102717 ARU 95102717ARU 95102717/14 ARU95102717/14 ARU 95102717/14ARU 95102717 ARU95102717 ARU 95102717ARU 95102717 ARU95102717 ARU 95102717A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новокузнецкий филиал общей реаниматологии РАНfiledCriticalНовокузнецкий филиал общей реаниматологии РАН
Priority to RU95102717/14ApriorityCriticalpatent/RU95102717A/en
Publication of RU95102717ApublicationCriticalpatent/RU95102717A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
FIELD: medicine; surgery. SUBSTANCE: method involves 1-2 seances of intravascular laser irradiation of blood (7 mW) for 60-80 min and hyperbaric oxygenation after 2 days of the postoperative period. EFFECT: lower mortality; shorter treatment period.
Claims (1)
Изобретение относится к медицине, а именно к реаниматологии и хирургии, для лечения хирургического сепсиса, гнойного перитонита, гнойного холангита, деструктивных форм холецистита и других гнойно-септических осложнений послеоперационного периода. Цель изобретения - снижение сроков лечения и смертности у больных с гнойно-септическими осложнениями. Это достигается тем, что в первые сутки после операционного периода проводят 1 - 2 сеанса внутрисосудистого лазерного облучения крови плотностью мощности 7 мВТ в течение 60 - 80 мин, гипербарическую оксигенацию начинают с двух суток послеоперационного периода.The invention relates to medicine, namely to resuscitation and surgery, for the treatment of surgical sepsis, purulent peritonitis, purulent cholangitis, destructive forms of cholecystitis and other purulent-septic complications of the postoperative period. The purpose of the invention is the reduction of treatment time and mortality in patients with purulent-septic complications. This is achieved by the fact that on the first day after the operation period 1 - 2 sessions of intravascular laser blood irradiation with a power density of 7 mW for 60 - 80 minutes are carried out, hyperbaric oxygenation begins from two days after the postoperative period.
RU95102717/14A1995-02-231995-02-23Method for treatment of purulent septic complications
RU95102717A
(en)